BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Lu Tang

Lu Tang contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
MethodologyMachine LearningApplicationsComputationNetworking and Internet Architecturestat.OT

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
7works
0followers
6topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

7 published item(s)

preprint2023arXiv

Covariate-guided Bayesian mixture model for multivariate time series

With rapid development of techniques to measure brain activity and structure, statistical methods for analyzing modern brain-imaging play an important role in the advancement of science. Imaging data that measure brain function are usually multivariate time series and are heterogeneous across both imaging sources and subjects, which lead to various statistical and computational challenges. In this paper, we propose a group-based method to cluster a collection of multivariate time series via a Bayesian mixture of smoothing splines. Our method assumes each multivariate time series is a mixture of multiple components with different mixing weights. Time-independent covariates are assumed to be associated with the mixture components and are incorporated via logistic weights of a mixture-of-experts model. We formulate this approach under a fully Bayesian framework using Gibbs sampling where the number of components is selected based on a deviance information criterion. The proposed method is compared to existing methods via simulation studies and is applied to a study on functional near-infrared spectroscopy (fNIRS), which aims to understand infant emotional reactivity and recovery from stress. The results reveal distinct patterns of brain activity, as well as associations between these patterns and selected covariates.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

A Tree-based Model Averaging Approach for Personalized Treatment Effect Estimation from Heterogeneous Data Sources

Accurately estimating personalized treatment effects within a study site (e.g., a hospital) has been challenging due to limited sample size. Furthermore, privacy considerations and lack of resources prevent a site from leveraging subject-level data from other sites. We propose a tree-based model averaging approach to improve the estimation accuracy of conditional average treatment effects (CATE) at a target site by leveraging models derived from other potentially heterogeneous sites, without them sharing subject-level data. To our best knowledge, there is no established model averaging approach for distributed data with a focus on improving the estimation of treatment effects. Specifically, under distributed data networks, our framework provides an interpretable tree-based ensemble of CATE estimators that joins models across study sites, while actively modeling the heterogeneity in data sources through site partitioning. The performance of this approach is demonstrated by a real-world study of the causal effects of oxygen therapy on hospital survival rate and backed up by comprehensive simulation results.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity

Allocating patients to treatment arms during a trial based on the observed responses accumulated prior to the decision point, and sequential adaptation of this allocation,, could minimize the expected number of failures or maximize total benefit to patients. In this study, we developed a Bayesian response adaptive randomization (RAR) design targeting the endpoint of organ support-free days (OSFD) for patients admitted to the intensive care units (ICU). The OSFD is a mixture of mortality and morbidity assessed by the number of days of free of organ support within a predetermined time-window post-randomization. In the past, researchers treated OSFD as an ordinal outcome variable where the lowest category is death. We propose a novel RAR design for a composite endpoint of mortality and morbidity, e.g., OSFD, by using a Bayesian mixture model with a Markov chain Monte Carlo sampling to estimate the posterior probability of OSFD and determine treatment allocation ratios at each interim. Simulations were conducted to compare the performance of our proposed design under various randomization rules and different alpha spending functions. The results show that our RAR design using Bayesian inference allocated more patients to the better performing arm(s) compared to other existing adaptive rules while assuring adequate power and type I error rate control for the across a range of plausible clinical scenarios.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

A Fast and Compact Invertible Sketch for Network-Wide Heavy Flow Detection

Fast detection of heavy flows (e.g., heavy hitters and heavy changers) in massive network traffic is challenging due to the stringent requirements of fast packet processing and limited resource availability. Invertible sketches are summary data structures that can recover heavy flows with small memory footprints and bounded errors, yet existing invertible sketches incur high memory access overhead that leads to performance degradation. We present MV-Sketch, a fast and compact invertible sketch that supports heavy flow detection with small and static memory allocation. MV-Sketch tracks candidate heavy flows inside the sketch data structure via the idea of majority voting, such that it incurs small memory access overhead in both update and query operations, while achieving high detection accuracy. We present theoretical analysis on the memory usage, performance, and accuracy of MV-Sketch in both local and network-wide scenarios. We further show how MV-Sketch can be implemented and deployed on P4-based programmable switches subject to hardware deployment constraints. We conduct evaluation in both software and hardware environments. Trace-driven evaluation in software shows that MV-Sketch achieves higher accuracy than existing invertible sketches, with up to 3.38x throughput gain. We also show how to boost the performance of MV-Sketch with SIMD instructions. Furthermore, we evaluate MV-Sketch on a Barefoot Tofino switch and show how MV-Sketch achieves line-rate measurement with limited hardware resource overhead.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

A sparse negative binomial mixture model for clustering RNA-seq count data

Clustering with variable selection is a challenging yet critical task for modern small-n-large-p data. Existing methods based on sparse Gaussian mixture models or sparse K-means provide solutions to continuous data. With the prevalence of RNA-seq technology and lack of count data modeling for clustering, the current practice is to normalize count expression data into continuous measures and apply existing models with Gaussian assumption. In this paper, we develop a negative binomial mixture model with lasso or fused lasso gene regularization to cluster samples (small n) with high-dimensional gene features (large p). EM algorithm and Bayesian information criterion are used for inference and determining tuning parameters. The method is compared with existing methods using extensive simulations and two real transcriptomic applications in rat brain and breast cancer studies. The result shows superior performance of the proposed count data model in clustering accuracy, feature selection and biological interpretation in pathways.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Distributed Simultaneous Inference in Generalized Linear Models via Confidence Distribution

We propose a distributed method for simultaneous inference for datasets with sample size much larger than the number of covariates, i.e., N >> p, in the generalized linear models framework. When such datasets are too big to be analyzed entirely by a single centralized computer, or when datasets are already stored in distributed database systems, the strategy of divide-and-combine has been the method of choice for scalability. Due to partition, the sub-dataset sample sizes may be uneven and some possibly close to p, which calls for regularization techniques to improve numerical stability. However, there is a lack of clear theoretical justification and practical guidelines to combine results obtained from separate regularized estimators, especially when the final objective is simultaneous inference for a group of regression parameters. In this paper, we develop a strategy to combine bias-corrected lasso-type estimates by using confidence distributions. We show that the resulting combined estimator achieves the same estimation efficiency as that of the maximum likelihood estimator using the centralized data. As demonstrated by simulated and real data examples, our divide-and-combine method yields nearly identical inference as the centralized benchmark.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Outcome-Guided Disease Subtyping for High-Dimensional Omics Data

High-throughput microarray and sequencing technology have been used to identify disease subtypes that could not be observed otherwise by using clinical variables alone. The classical unsupervised clustering strategy concerns primarily the identification of subpopulations that have similar patterns in gene features. However, as the features corresponding to irrelevant confounders (e.g. gender or age) may dominate the clustering process, the resulting clusters may or may not capture clinically meaningful disease subtypes. This gives rise to a fundamental problem: can we find a subtyping procedure guided by a pre-specified disease outcome? Existing methods, such as supervised clustering, apply a two-stage approach and depend on an arbitrary number of selected features associated with outcome. In this paper, we propose a unified latent generative model to perform outcome-guided disease subtyping constructed from omics data, which improves the resulting subtypes concerning the disease of interest. Feature selection is embedded in a regularization regression. A modified EM algorithm is applied for numerical computation and parameter estimation. The proposed method performs feature selection, latent subtype characterization and outcome prediction simultaneously. To account for possible outliers or violation of mixture Gaussian assumption, we incorporate robust estimation using adaptive Huber or median-truncated loss function. Extensive simulations and an application to complex lung diseases with transcriptomic and clinical data demonstrate the ability of the proposed method to identify clinically relevant disease subtypes and signature genes suitable to explore toward precision medicine.

0 citations0 reviewsNo code linkedOpen access